Jci_page_head_homepage_01 Jci_page_head_homepage_02
Anne Jarry, Céline Bossard, Chantal Bou-Hanna, Damien Masson, Eric Espaze, Marc G. Denis, Christian L. Laboisse
Published in Volume 118, Issue 3
J Clin Invest. 2008; 118(3):1132–1142 doi:10.1172/JCI32140
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 8
Involvement of bacterial LPS in the production of IFN-γ and epithelial barrier disruption in IL-10–depleted mucosa explant cultures.

Mucosa explant cultures were incubated for 48 h with or without anti–IL-10 antibodies and the LPS scavenger polymyxin B (Pmx, 10 μg/ml). (A) IFN-γ mRNA levels were measured by real-time PCR (left); IFN-γ secretion was measured by ELISA (right). In IL-10–depleted explant cultures, polymyxin B abolished IFN-γ upregulation, at both mRNA and protein levels. Horizontal lines represent mean values of 4 (left) or 5 (right) different experiments. (B) Immunoperoxidase staining of colonic epithelial cells with the anti-cytokeratin antibody KL-1 on paraffin sections. Polymyxin B prevented epithelial barrier disruption in IL-10–depleted mucosa explants. Original magnification, ×200. (C) KL-1–positive intact crypt counts in 48-h mucosa explant cultures treated or not with anti–IL-10 antibodies and polymyxin B. Values are mean ± SEM of 5 different experiments.